Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
ARSK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
EEF1E1-BLOC1S5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NRROS - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100996286 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
KBTBD4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SEPT4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EML3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
AIG1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
RIPK4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
BBS9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
UFL1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SAMD4A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM63B - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ABHD2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LMAN2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NAA35 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on